|
|
Article: Teva Pharmaceutical Industries Ltd. Comments On the Tel-Aviv District Court Decision Regarding Fluoxetine.
- Article from:
- Business Wire
- Article date:
- December 2, 1998
CopyrightCOPYRIGHT 1998 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JERUSALEM, Israel--(BUSINESS WIRE)--Dec. 2, 1998--
- No Significant Impact is Expected on The Company's Results -
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVIY) issued the following statement in response to news reports regarding the Tel-Aviv District Court decision published yesterday regarding Fluoxetine (the active ingredient in Prozac(r)), Teva has issued the following statement:
Based on the initial review of our legal counsel, it appears likely that Teva will appeal the court decision.
Based on an initial review of the court decision, the company does not expect that this decision will have a significant impact on the ...